Prospect of stem cell therapy and regenerative medicine in osteoporosis
The field of cell therapy and regenerative medicine can hold the promise of restoring normal
tissues structure and function. Additionally, the main targets of stem cell-based therapies are …
tissues structure and function. Additionally, the main targets of stem cell-based therapies are …
The therapeutic potential of mesenchymal stem cells in treating osteoporosis
T Chen, T Yang, W Zhang, J Shao - Biological research, 2021 - Springer
Osteoporosis (OP), a common systemic metabolic bone disease, is characterized by low
bone mass, increasing bone fragility and a high risk of fracture. At present, the clinical …
bone mass, increasing bone fragility and a high risk of fracture. At present, the clinical …
Osteoporosis: the current status of mesenchymal stem cell-based therapy
J Phetfong, T Sanvoranart, K Nartprayut… - Cellular & molecular …, 2016 - Springer
Osteoporosis, or bone loss, is a progressive, systemic skeletal disease that affects millions of
people worldwide. Osteoporosis is generally age related, and it is underdiagnosed because …
people worldwide. Osteoporosis is generally age related, and it is underdiagnosed because …
Prospect of mesenchymal stem cells in therapy of osteoporosis: a review
Osteoporosis is a systemic skeletal disease associated with reduced bone strong point that
results in raised fracture risk, with decreased bone strength, leading to reduced bone …
results in raised fracture risk, with decreased bone strength, leading to reduced bone …
Stem cells in osteoporosis: from biology to new therapeutic approaches
V Paspaliaris, G Kolios - Stem Cells International, 2019 - Wiley Online Library
Osteoporosis is a systemic disease that affects the skeleton, causing reduction of bone
density and mass, resulting in destruction of bone microstructure and increased risk of bone …
density and mass, resulting in destruction of bone microstructure and increased risk of bone …
Stem cell therapy for osteoporosis
Osteoporosis is a debilitating disease that affects millions of people worldwide. Current
osteoporosis treatments are predominantly bone-resorbing drugs that are associated with …
osteoporosis treatments are predominantly bone-resorbing drugs that are associated with …
Mesenchymal stem cells: cell fate decision to osteoblast or adipocyte and application in osteoporosis treatment
L Hu, C Yin, F Zhao, A Ali, J Ma, A Qian - International Journal of …, 2018 - mdpi.com
Osteoporosis is a progressive skeletal disease characterized by decreased bone mass and
degraded bone microstructure, which leads to increased bone fragility and risks of bone …
degraded bone microstructure, which leads to increased bone fragility and risks of bone …
Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis
Y Jiang, P Zhang, X Zhang, L Lv, Y Zhou - Cell proliferation, 2021 - Wiley Online Library
Osteoporosis is a systemic metabolic bone disease with characteristics of bone loss and
microstructural degeneration. The personal and societal costs of osteoporosis are …
microstructural degeneration. The personal and societal costs of osteoporosis are …
Bone regeneration and stem cells
K Arvidson, BM Abdallah, LA Applegate… - Journal of cellular …, 2011 - Wiley Online Library
Introduction• Bone fracture healing and healing problems• Biomaterial scaffolds and tissue
engineering in bone formation‐Bone tissue engineering‐Biomaterial scaffolds‐Synthetic …
engineering in bone formation‐Bone tissue engineering‐Biomaterial scaffolds‐Synthetic …
[HTML][HTML] Differentiation of bone marrow mesenchymal stem cells in osteoblasts and adipocytes and its role in treatment of osteoporosis
C Wang, H Meng, X Wang, C Zhao… - … medical journal of …, 2016 - ncbi.nlm.nih.gov
Osteoporosis is a systemic metabolic bone disorder characterized by a decrease in bone
mass and degradation of the bone microstructure, leaving bones that are fragile and prone …
mass and degradation of the bone microstructure, leaving bones that are fragile and prone …